Stocks and Investing Stocks and Investing
Mon, July 20, 2020

Evan Seigerman Maintained (VRTX) at Buy with Increased Target to $328 on, Jul 20th, 2020


Published on 2024-10-27 09:55:55 - WOPRAI, Evan Seigerman
  Print publication without navigation


Evan Seigerman of Credit Suisse, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $298 to $328 on, Jul 20th, 2020.

Evan has made no other calls on VRTX in the last 4 months.



There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 3 agree with Evan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Increased Target to $300 on, Wednesday, July 8th, 2020
  • Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $264 on, Monday, July 6th, 2020
  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Increased Target to $263 on, Thursday, April 30th, 2020


These are the ratings of the 10 analyists that currently disagree with Evan


  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $330 on, Thursday, July 2nd, 2020
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $325 on, Friday, June 12th, 2020
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $320 on, Friday, May 15th, 2020
  • Kevin Huang of "CFRA" Maintained at Strong Buy with Increased Target to $297 on, Thursday, April 30th, 2020
  • Liisa Bayko of "JMP Securities" Maintained at Buy with Increased Target to $285 on, Thursday, April 30th, 2020
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $285 on, Thursday, April 30th, 2020
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $283 on, Thursday, April 30th, 2020
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $305 on, Thursday, April 30th, 2020
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $295 on, Thursday, April 30th, 2020
  • Gena Wang of "Barclays" Initiated at Buy on, Friday, March 20th, 2020
Contributing Sources